About this trial
Current evidence suggests that noninvasive positive pressure ventilation (NIPPV) is more effective than continuous positive airway pressure (CPAP) in preventing respiratory failure in preterm infants with respiratory distress syndrome (RDS), both as initial and post-extubation support. NIPPV may be delivered in synchronized (sNIPPV) or non-synchronized (nsNIPPV) modes, with sNIPPV offering clear benefits by coordinating support with the infant's own breathing. Recent studies indicate sNIPPV is superior to nsNIPPV in preventing respiratory failure, though the intrapulmonary mechanisms behind this advantage remain unclear. To address this, the present study uses Electrical Impedance Tomography (EIT) to evaluate how lung volume changes during different types of breaths and ventilator inflations - spontaneous breaths, synchronized inflations, non-synchronized inflations, and backup inflations - in preterm infants receiving sNIPPV.
Eligibility criteria
Qualifiers
Written informed consent by one or both parents or legal guardians
Gestational age at birth < 30 0/7 weeks
Infants on sNIPPV respiratory support
Below 4 weeks chronological age
Disqualifiers
Severe congenital malformation adversely affecting lung aeration or perfusion (e.g., congenital heart defects)
Too ill/unstable in the opinion of the treating physician.
Trial design
Treatments tested in this trial
- Electrical Impedance Tomography (EIT)
Treatment groups
Sponsors and collaborators
University of Zurich
Lead sponsor
University Hospital, Zürich
Collaborator